COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2598: Articles 25971-25980  | Next

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
Diez, J. M., Romero, C., Vergara Alert, J., Bello Perez, M., Rodon, J., Honrubia, J. M., Segales, J., Sola, I., Enjuanes, L., Gajardo, R.
10.1101/2020.06.19.160879 — Posted: 2020-06-19
Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window
Gouveia, D., Miotello, G., Gallais, F., Gaillard, J.-C., Debroas, S., Bellanger, L., Lavigne, J.-P., Sotto, A., Grenga, L., Pible, O., Armengaud, J.
10.1101/2020.06.19.161000 — Posted: 2020-06-19
Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates
Savastano, A., Ibanez-de-Opakua, A., Rankovic, M., Zweckstetter, M.
10.1101/2020.06.18.160648 — Posted: 2020-06-19
ARDS and Cytokine Storm in SARS-CoV-2 Infected Caribbean Vervets
Blair, R. V., Vaccari, M., Doyle-Meyers, L. A., Roy, C. J., Russell-Lodrigue, K., Fahlberg, M., Monjure, C. J., Beddingfield, B., Plante, K. S., Plante, J. A., Weaver, S. C., Qin, X., Midkiff, C. C., Lehmicke, G., Golden, N., Threeton, B., Penney, T., Allers, C., Barnes, M. B., Pattison, M., Datta, P. K., Maness, N. J., Birnbaum, A., Bohm, R. P., Rappaport, J.
10.1101/2020.06.18.157933 — Posted: 2020-06-19
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2
Dittmar, M., Lee, J. S., Whig, K., Segrist, E., Li, M., Jurado, K., Samby, K., Ramage, H., Schultz, D., Cherry, S.
10.1101/2020.06.19.161042 — Posted: 2020-06-19 Discussion: Onsite | Offsite
A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge
Yahalom-Ronen, Y., Tamir, H., Melamed, S., Politi, B., Shifman, O., Achdout, H., B. Vitner, E., Israeli, O., Milrot, E., Stein, D., Cohen-Gihon, I., Lazar, S., Gutman, H., Glinert, I., Cherry, L., Vagima, Y., Lazar, S., Weiss, S., Ben-Shmuel, A., Avraham, R., Puni, R., Lupu, E., Bar David, E., Sittner, A., Erez, N., Zichel, R., Mamroud, E., Mazor, O., Levy, H., Laskar, O., Yitzhaki, S., C. Shapira, S., Zvi, A., Beth-Din, A., Paran, N., Israely, T.
10.1101/2020.06.18.160655 — Posted: 2020-06-19 Discussion: Onsite
Identification of a critical horseshoe-shaped region in the nsp5 (Mpro, 3CLpro) protease interdomain loop (IDL) of coronavirus mouse hepatitis virus (MHV)
Nick, B. C., Pandya, M. C., Lu, X., Franke, M. E., Callahan, S. M., Hasik, E. F., Berthrong, S. T., Denison, M. R., Stobart, C. C.
10.1101/2020.06.18.160671 — Posted: 2020-06-19
Mechanism and inhibition of SARS-CoV-2 PLpro
Klemm, T., Ebert, G., Calleja, D. J., Allison, C. C., Richardson, L. W., Bernardini, J. P., Lu, B. G. C., Kuchel, N. W., Grohmann, C., Shibata, Y., Gan, Z. Y., Cooney, J. P., Doerflinger, M., Au, A. E., Blackmore, T. R., Geurink, P. P., Ovaa, H., Newman, J., Riboldi-Tunnicliffe, A., Czabotar, P. E., Mitchell, J. P., Feltham, R., Lechtenberg, B. C., Lowes, K. N., Dewson, G., Pellegrini, M., Lessene, G., Komander, D.
10.1101/2020.06.18.160614 — Posted: 2020-06-19 Discussion: Onsite
Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19
Vogelzang, E. H., Loeff, F. C., Derksen, N. I., Kruithof, S., Ooijevaar-de Heer, P., van Mierlo, G., Linty, F., Mok, J. Y., van Esch, W., de Bruin, S., Vlaar, A. P., Seppen, B., Leeuw, M., van Oudheusden, A. J., Buiting, A. G., Jim, K. K., Vrielink, H., Swaneveld, F., Vidarsson, G., van der Schoot, C. E., Wever, P., Li, W., van Kuppeveld, F. J., Murk, J.-L., Bosch, B. J., Wolbink, G. J., Rispens, T.
10.1101/2020.06.17.20133793 — Posted: 2020-06-19
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis of confounder-adjusted 20212 hospitalized patients
Kim, M. S., An, M. H., Kim, W. J., Hwang, T.-H.
10.1101/2020.06.15.20132407 — Posted: 2020-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).